Back to Search
Start Over
Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.
- Source :
-
Vaccine [Vaccine] 2017 Aug 16; Vol. 35 (35 Pt B), pp. 4561-4568. Date of Electronic Publication: 2017 Jul 17. - Publication Year :
- 2017
-
Abstract
- Background: In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a catch-up campaign for children aged <5years in Kilifi County. In a post-vaccination surveillance study based in Kilifi, there was a substantial decline in invasive pneumococcal disease (IPD). However, given the continued circulation of the vaccine serotypes it is possible that vaccine-serotype disease may re-emerge once the effects of the catch-up campaign wear off.<br />Methods: We developed a compartmental, age-structured dynamic model of pneumococcal carriage and invasive disease for three serotype groups: the 10-valent vaccine serotypes and two groups of non-vaccine serotypes based on their susceptibility to mutual competition. The model was calibrated to age- and serotype-specific data on carriage and IPD in the pre-vaccination era and used to predict carriage prevalence and IPD up to ten years post-vaccination in Kilifi. The model was validated against the observed carriage prevalence after vaccine introduction.<br />Results: The model predicts a sustained reduction in vaccine-type pneumococcal carriage prevalence from 33% to 8% in infants and from 30% to 8% in 1-5year olds over the 10-year period following vaccine introduction. The incidence of IPD is predicted to decline across all age groups resulting in an overall reduction of 56% in the population, corresponding to 10.4 cases per 100,000 per year. The vaccine-type IPD incidence is estimated to decline by 83% while non-vaccine-type IPD incidence is predicted to increase by 52%. The model's predictions of carriage prevalence agrees well with the observed data in the first five years post-vaccination.<br />Conclusion: We predict a sustained and substantial decline in IPD through PCV vaccination and that the current regimen is insufficient to fully eliminate vaccine-serotype circulation in the model. We show that the observed impact is likely to be sustained despite waning effects of the catch-up campaign.<br /> (Copyright © 2017 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Subjects :
- Carrier State microbiology
Child, Preschool
Female
Humans
Infant
Kenya epidemiology
Male
Models, Theoretical
Nasopharynx microbiology
Pneumococcal Infections microbiology
Pneumococcal Vaccines administration & dosage
Pneumococcal Vaccines immunology
Serogroup
Streptococcus pneumoniae immunology
Streptococcus pneumoniae isolation & purification
Vaccination statistics & numerical data
Carrier State epidemiology
Epidemiological Monitoring
Pneumococcal Infections epidemiology
Pneumococcal Infections prevention & control
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2518
- Volume :
- 35
- Issue :
- 35 Pt B
- Database :
- MEDLINE
- Journal :
- Vaccine
- Publication Type :
- Academic Journal
- Accession number :
- 28729018
- Full Text :
- https://doi.org/10.1016/j.vaccine.2017.07.019